Takahiro Tsujimura

2.7k total citations
96 papers, 2.1k citations indexed

About

Takahiro Tsujimura is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Takahiro Tsujimura has authored 96 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 33 papers in Immunology and 18 papers in Surgery. Recurrent topics in Takahiro Tsujimura's work include Immune Cell Function and Interaction (17 papers), CAR-T cell therapy research (14 papers) and T-cell and B-cell Immunology (10 papers). Takahiro Tsujimura is often cited by papers focused on Immune Cell Function and Interaction (17 papers), CAR-T cell therapy research (14 papers) and T-cell and B-cell Immunology (10 papers). Takahiro Tsujimura collaborates with scholars based in Japan and United States. Takahiro Tsujimura's co-authors include Y Kitamura, H Fujiwara, Ichiro Nakagawa, K Isozaki, Ryosuke Matsuda, Tsutomu Nakazawa, Keishi Matsumoto, Toshiyuki Hamaoka, T Furitsu and Y Matsuzawa and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Takahiro Tsujimura

94 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takahiro Tsujimura Japan 25 896 727 466 353 205 96 2.1k
Graziella Bellone Italy 30 1.1k 1.3× 972 1.3× 713 1.5× 322 0.9× 192 0.9× 103 2.8k
Anne E. Hughes United Kingdom 26 741 0.8× 574 0.8× 1.0k 2.2× 198 0.6× 215 1.0× 59 3.0k
Vincent Hurez United States 29 1.4k 1.6× 721 1.0× 601 1.3× 211 0.6× 154 0.8× 60 2.6k
Assia Eljaafari France 25 806 0.9× 359 0.5× 422 0.9× 332 0.9× 133 0.6× 57 2.1k
Elias Shezen Israel 26 640 0.7× 396 0.5× 904 1.9× 429 1.2× 165 0.8× 60 2.3k
Prabhakar Putheti United States 19 993 1.1× 281 0.4× 326 0.7× 308 0.9× 96 0.5× 35 1.9k
Ronald J. Diebold United States 11 966 1.1× 608 0.8× 1.7k 3.7× 265 0.8× 274 1.3× 11 3.3k
Gary Elliott United States 16 612 0.7× 440 0.6× 930 2.0× 239 0.7× 94 0.5× 22 1.8k
Leonor Leider–Trejo Israel 21 716 0.8× 924 1.3× 1.2k 2.6× 565 1.6× 233 1.1× 35 3.0k
Y Ohsugi Japan 20 1.0k 1.1× 1.1k 1.5× 1.1k 2.4× 138 0.4× 115 0.6× 38 3.1k

Countries citing papers authored by Takahiro Tsujimura

Since Specialization
Citations

This map shows the geographic impact of Takahiro Tsujimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takahiro Tsujimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takahiro Tsujimura more than expected).

Fields of papers citing papers by Takahiro Tsujimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takahiro Tsujimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takahiro Tsujimura. The network helps show where Takahiro Tsujimura may publish in the future.

Co-authorship network of co-authors of Takahiro Tsujimura

This figure shows the co-authorship network connecting the top 25 collaborators of Takahiro Tsujimura. A scholar is included among the top collaborators of Takahiro Tsujimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takahiro Tsujimura. Takahiro Tsujimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakazawa, Tsutomu, Takayuki Morimoto, Kengo Yamada, et al.. (2024). Characterization of HIF-1α Knockout Primary Human Natural Killer Cells Including Populations in Allogeneic Glioblastoma. International Journal of Molecular Sciences. 25(11). 5896–5896. 2 indexed citations
2.
Morimoto, Takayuki, Tsutomu Nakazawa, Ryosuke Matsuda, et al.. (2024). Antitumor Effects of Intravenous Natural Killer Cell Infusion in an Orthotopic Glioblastoma Xenograft Murine Model and Gene Expression Profile Analysis. International Journal of Molecular Sciences. 25(4). 2435–2435.
3.
Morimoto, Takayuki, Tsutomu Nakazawa, Ryosuke Matsuda, et al.. (2024). Bulk RNA sequencing reveals the comprehensive genetic characteristics of human cord blood-derived natural killer cells. Regenerative Therapy. 25. 367–376. 1 indexed citations
4.
Morimoto, Takayuki, et al.. (2023). Natural Killer Cell-Based Immunotherapy against Glioblastoma. International Journal of Molecular Sciences. 24(3). 2111–2111. 30 indexed citations
5.
Nakazawa, Tsutomu, Takayuki Morimoto, Ryosuke Matsuda, et al.. (2023). An efficient feeder-free and chemically-defined expansion strategy for highly purified natural killer cells derived from human cord blood. Regenerative Therapy. 24. 32–42. 7 indexed citations
6.
Nakazawa, Tsutomu, Ryosuke Matsuda, Takayuki Morimoto, et al.. (2023). Therapeutic Anti-KIR Antibody of 1–7F9 Attenuates the Antitumor Effects of Expanded and Activated Human Primary Natural Killer Cells on In Vitro Glioblastoma-like Cells and Orthotopic Tumors Derived Therefrom. International Journal of Molecular Sciences. 24(18). 14183–14183. 2 indexed citations
7.
Nakazawa, Tsutomu, Takayuki Morimoto, Ryosuke Matsuda, et al.. (2022). Capability of Human Dendritic Cells Pulsed with Autologous Induced Pluripotent Stem Cell Lysate to Induce Cytotoxic T Lymphocytes against HLA-A33-Matched Cancer Cells. International Journal of Molecular Sciences. 23(21). 12992–12992. 7 indexed citations
8.
Nakazawa, Tsutomu, Ryosuke Matsuda, Takayuki Morimoto, et al.. (2021). Ex Vivo Expanded and Activated Natural Killer Cells Prolong the Overall Survival of Mice with Glioblastoma-like Cell-Derived Tumors. International Journal of Molecular Sciences. 22(18). 9975–9975. 11 indexed citations
9.
Tanaka, Yoshitaka, Tsutomu Nakazawa, Mitsutoshi Nakamura, et al.. (2019). Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro. PLoS ONE. 14(3). e0212455–e0212455. 32 indexed citations
10.
Yasukawa, Motoaki, Tsutomu Nakazawa, Takeshi Kawaguchi, et al.. (2016). Minodronic Acid in Combination with γδT Cells Induces Apoptosis of Non-small Cell Lung Carcinoma Cell Lines. Anticancer Research. 36(11). 5883–5886. 1 indexed citations
11.
Asai, Hirohide, Makito Hirano, Fukashi Udaka, et al.. (2007). Sympathetic disturbances increase risk of sudden cardiac arrest in sporadic ALS. Journal of the Neurological Sciences. 254(1-2). 78–83. 61 indexed citations
12.
Toyosawa, Satoru, Y. Tomita, Mitsunobu Kishino, et al.. (2004). Expression of dentin matrix protein 1 in tumors causing oncogenic osteomalacia. Modern Pathology. 17(5). 573–578. 35 indexed citations
13.
Iwata, Nobuko, Kenji Hattori, Takashi Nakagawa, & Takahiro Tsujimura. (2002). Hemangioma of the nasal cavity. Auris Nasus Larynx. 29(4). 335–339. 54 indexed citations
14.
Mukai, Takao, Ping Gao, N. Yamaguchi, et al.. (2002). A non-peptide CCR5 antagonist inhibits collagen-induced arthritis by modulating T cell migration without affecting anti-collagen T cell responses. European Journal of Immunology. 32(8). 2124–2124. 96 indexed citations
15.
Tsujimura, Takahiro, et al.. (1999). Why couldn’t an accurate diagnosis be made? An analysis of 1044 consecutive autopsy cases. Pathology International. 49(5). 408–410. 13 indexed citations
16.
Izumi, Yuishin, Katsuhiko Sakaguchi, Fukashi Udaka, Takahiro Tsujimura, & Masakuni Kameyama. (1999). A Patient with Meningeal Carcinomatosis Accompanied by a Small Pituitary Metastatic Lesion from Gastric Cancer Who Developed Cerebral Salt Wasting Syndrome.. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 36(9). 657–662. 9 indexed citations
17.
Saitoh, Masato, et al.. (1996). Tenascin expression in adenoid basal cell carcinoma of the skin.. PubMed. 16(1). 129–34. 3 indexed citations
18.
Mu, Jie, Yoshiko Abe, Tateki Tsutsui, et al.. (1996). Inhibition of Growth and Metastasis of Ovarian Carcinoma by Administering a Drug Capable of Interfering with Vascular Endothelial Growth Factor Activity. Japanese Journal of Cancer Research. 87(9). 963–971. 40 indexed citations
19.
Nagasaka, Akio, S. Yoshida, Shinichi Kato, et al.. (1993). Enhancement of DNA Polymerase β Activity in the Pituitary Gland by Hormonal Feedback. Hormone and Metabolic Research. 25(8). 403–406. 1 indexed citations
20.
Noda, Yutaka, et al.. (1987). Immunohistochemical Identification of Epithelial Membrane Antigen in Sweat Gland Tumours by the Use of a Monoclonal Antibody. Pathology - Research and Practice. 182(6). 797–804. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026